Effects of neferine on the pharmacokinetics of amiodarone in rats

Biomedical Chromatography

Volumn 25, Issue 8, 2011, Pages 858-866

  Wan, Jiadao ^a   Zhao, Libo ^b   Xu, Chuan ^a   Zhang, Shaohui ^a   Zhang, Zhixin ^a   Zeng, Cheng ^a   Chang, Mujun ^a   Xiao, Junhua ^a   Wang, Jialing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Amiodarone; Cytochrome P450; Neferine; Pharmacokinetic interaction; RP HPLC

Indexed keywords

KETONES; RATS;

AMIODARONE; BENZOFURANS; CYTOCHROMES P450; INTRAGASTRIC ADMINISTRATION; NEFERINE; NELUMBO NUCIFERA; PHARMACOKINETICS INTERACTIONS; PULMONARY FIBROSIS; RP-HPLC; VENTRICULAR ARRHYTHMIAS;

PHARMACOKINETICS;

AMIODARONE; NEFERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG HALF LIFE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TIME TO MAXIMUM PLASMA CONCENTRATION;

NELUMBO NUCIFERA; RATTUS;

EID: 79960010889     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1535     Document Type: Article

References (25)

1. Card JW, Racz WJ, Brien JF, Margolin SB and Massey TE. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity. Toxicology Science 2003a; 75(1): 169-180.
2. Card JW, Racz WJ, Brien JF and Massey TE. Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction. Journal of Pharmacology and Experimental Therapy 2003b; 304(1): 277-283.
3. Elsherbiny ME, El-Kadi AO and Brocks DR. The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. Journal of Pharmacology and Pharmaceutical Science 2008; 11(1): 147-259.
4. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV and Singer DE. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? Journal of the American Medical Association 2003; 290(20): 2685-2692.
5. Gu DF, Li XL, Qi ZP, Shi SS, Hu MQ, Liu DM, She CB, Lv YJ, Li BX and Yang BF. Blockade of HERG K+ channel by isoquinoline alkaloid neferine in the stable transfected HEK293 cells. Naunyn Schmiedeberg's Archiv für Pharmacologie 2009; 380(2): 143-151.
6. Harder S and Thurmann P. Clinically important drug interactions with anticoagulants. An update. Clinical Pharmacokinetics 1996; 30(6): 416-444.
7. Hirano A, Kanehiro A, Ono K, Ito W, Yoshida A, Okada C, Nakashima H, Tanimoto Y, Kataoka M, Gelfand EW and Tanimoto M. Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. American Journal of Respiratory Cell and Molecular Biology 2006; 35(3): 366-377.
8. Huang Y, Bai Y, Zhao L, Hu T, Hu B, Wang J and Xiang J. Pharmacokinetics and metabolism of neferine in rats after a single oral administration. Biopharmaceutical Drug Disposition 2007; 28(7): 361-372.
9. Kathofer S, Thomas D and Karle CA. The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovascular Drug Review 2005; 23(3): 217-230.
10. Kober L, Torp-Pedersen C, McMurray JJ, Gotzsche O, Levy S, Crijns H, Amlie J and Carlsen J. Increased mortality after dronedarone therapy for severe heart failure. New England Journal of Medicine 2008; 358(25): 2678-2687.
11. Kurnik D, Loebstein R, Farfel Z, Ezra D, Halkin H and Olchovsky D. Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland. Medicine (Baltimore) 2004; 83(2): 107-113.
12. Nikaido A, Tada T, Nakamura K, Murakami M, Banba K, Nishii N, Fuke S, Nagase S, Sakuragi S, Morita H, Ohe T and Kusano KF. Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity. International Journal of Cardiology 2010.
13. Oetgen WJ, Sobol SM, Tri TB, Heydorn WH and Rakita L. Amiodarone-digoxin interaction. Clinical and experimental observations. Chest 1984; 86(1): 75-79.
14. Punithavathi D, Venkatesan N and Babu M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. British Journal of Pharmacology 2003; 139(7): 1342-1350.
15. Qian JQ. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacologica Sinica 2002; 23(12): 1086-1092.
16. Sanoski CA and Bauman JL. Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy. Chest 2002; 121(1): 19-23.
17. Uhal BD, Wang R, Laukka J, Zhuang J, Soledad-Conrad V and Filippatos G. Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacology and Toxicology 2003; 92(2): 81-87.
18. Vassallo P and Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. Journal of the American Medical Association 2007; 298(11): 1312-1322.
19. Wells PS, Holbrook AM, Crowther NR and Hirsh J. Interactions of warfarin with drugs and food. Annals of Internal Medicine 1994; 121(9): 676-683.
20. Xiao JH, Zhang JH, Chen HL, Feng XL and Wang JL. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice. Planta Medica 2005a; 71(3): 225-230.
21. Xiao JH, Zhang YL, Ding LL, Feng XL and Wang JL. Effects of isoliensinine on proliferation of porcine coronary arterial smooth muscle cells induced by phenylephrine. Yao Xue Xue Bao 2005b; 40(2): 105-110.
22. Xiao JH, Zhang YL, Feng XL, Wang JL and Qian JQ. Effects of isoliensinine on angiotensin II-induced proliferation of porcine coronary arterial smooth muscle cells. Journal of Asian Natural Product Research 2006; 8(3): 209-216.
23. Yin Y, Dalal D, Liu Z, Wu J, Liu D, Lan X, Dai Y, Su L, Ling Z, She Q, Luo K, Woo K and Dong J. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. European Heart Journal 2006; 27(15): 1841-1846.
24. Zhao L, Wang X, Wu J, Jia Y, Wang W, Zhang S and Wang J. Improved RP-HPLC method to determine neferine in dog plasma and its application to pharmacokinetics. Journal of Chromatography B: Analytical Technology in Biomedicine and Life Sciences 2007; 857(2): 341-346.
25. Zhao L, Wang X, Chang Q, Xu J, Huang Y, Guo Q, Zhang S, Wang W, Chen X and Wang J. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. European Journal of Pharmacology 2010.